P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 197 500 KRW 0.66%
Market Cap: 2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Net Issuance of Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Issuance of Debt
-â‚©8.6B
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Issuance of Debt
-â‚©105.7B
CAGR 3-Years
-12%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Net Issuance of Debt
-â‚©95.5B
CAGR 3-Years
-326%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Net Issuance of Debt
â‚©101.8B
CAGR 3-Years
18%
CAGR 5-Years
1%
CAGR 10-Years
-1%
H
Hugel Inc
KOSDAQ:145020
Net Issuance of Debt
-â‚©2.1B
CAGR 3-Years
-8%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Issuance of Debt
â‚©14.3B
CAGR 3-Years
N/A
CAGR 5-Years
58%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
250 639.72 KRW
Undervaluation 21%
Intrinsic Value
Price
P

See Also

What is PharmaResearch Co Ltd's Net Issuance of Debt?
Net Issuance of Debt
-8.6B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Net Issuance of Debt amounts to -8.6B KRW.

What is PharmaResearch Co Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
19%

Over the last year, the Net Issuance of Debt growth was -297%.

Back to Top